Praxis Precision Medicines, Inc. (PRAX) › Shareholders' EquityPraxis Precision Medicines, Inc. (PRAX) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2018: -$41.04M2019: -$81.01M2020: $287.46M2021: $250.81M2022: $76.11M2023: $69.67M2024: $445.45M2025: $878.14M$878.14M2018Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$878.14M+97.1%2024$445.45M+539.4%2023$69.67M-8.5%2022$76.11M-69.7%2021$250.81M-12.7%2020$287.46M+454.9%2019-$81.01M-97.4%2018-$41.04M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share